TransMedics Group, Inc. TMDX

Updated: 11 Sep 2026

NASDAQ | Biotech | Medical Technology

No signal published yet

We already track TransMedics Group and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow TransMedics Group free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Medical Technology
We're already tracking TransMedics Group, Inc. — here are the latest events we've registered

Recent News

  • On August 4, 2026, TransMedics reported its second-quarter 2026 financial results, with total revenue increasing 21% year-over-year to $189.9 million and net income reaching $14.7 million. The company raised the low end of its full-year 2026 revenue guidance to between $737 million and $757 million. Additionally, on July 1, 2026, TransMedics completed a strategic investment in Germany-based PAD Aviation to establish a European air logistics network for organ transplants.

What Firelda Watch includes for TransMedics Group, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of TransMedics Group, Inc. will be delivered in the same format.

Want to follow TransMedics Group, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow TransMedics Group free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

TransMedics Group, Inc. TMDX
TransMedics Group — follow and we'll monitor it
Follow TransMedics Group free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.